New York Life Investment Management LLC Grows Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

New York Life Investment Management LLC raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 61,406 shares of the company’s stock after purchasing an additional 4,702 shares during the period. New York Life Investment Management LLC’s holdings in GE HealthCare Technologies were worth $4,801,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. LGT Financial Advisors LLC increased its stake in shares of GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after acquiring an additional 251 shares during the last quarter. Ashton Thomas Securities LLC acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at about $26,000. Capital Performance Advisors LLP acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at about $26,000. Darwin Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at about $31,000. Finally, Continuum Advisory LLC increased its stake in shares of GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after acquiring an additional 168 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Down 2.3 %

NASDAQ GEHC opened at $87.35 on Friday. The stock has a market cap of $39.94 billion, a PE ratio of 20.17, a P/E/G ratio of 3.19 and a beta of 1.15. The business has a 50 day moving average price of $86.17 and a two-hundred day moving average price of $86.10. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have recently commented on GEHC shares. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. Finally, Citigroup increased their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. One research analyst has rated the stock with a sell rating, three have given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.